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Background 
 
The Rift Valley fever (RVF) case study is being implemented by the International Livestock Research Institute 
(ILRI) in partnership with the Division of Disease Surveillance and Response, the Kenya Medical Research 
Institute, the Department of Veterinary Services, the School of Biological Studies and the Institute of 
Anthropology, Gender and African Studies, University of Nairobi and the Ministry of Public Health and 
Sanitation. 
The case study investigates whether land use change (through irrigation) promotes the occurrence and 
persistence of RVF. The case study has several components including human health, livestock health, 
entomology, ecology, socio-economics and anthropology. Study sites that have been identified for the work 
include Ijara Division in Ijara District and Bura and Hola irrigation schemes in Tana River District. The case study 
also intends to screen for other diseases that present similar signs as RVF (including Crimean-Congo 
Haemorrhagic Fever virus, yellow fever virus, Dengue fever virus, Ngari virus, Chikungunya, Brucella spp. 
[brucellosis], Coxiella burnetii [Q fever] and Leptospira spp. and malaria) in order to generate data that can be 
used to build capacity in differential diagnosis of febrile illnesses in the area. Initiation of a hospital survey was 
done. 
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Training summary 
 
Trainers: Bernard Bett (ILRI), Jason Rogena (ILRI), John Muriuki (ILRI) and Damaris Mwololo (ILRI) 
A training and hospital survey initiation involving the Dynamic Drivers of Disease in Africa consortium (DDDAC) 
RVF case study team and medical and laboratory officers from the health centres in the project sites (Ijara, 
Sangailu, Hola and Bura) was convened in Hola on 11-14 March 2014 at Paula Hotel (see Annex 1 for the list of 
participants). This aimed to (i) review the objectives, sampling procedures, ethical requirements and benefits of 
the hospital survey, (ii) develop work plans and (iii) initialize the sampling in all the four hospitals. 
The participants were taken through the objectives and study design of the project and the reasons why their 
area had been chosen as a study site. The participants were informed that the justification of using the study 
site was based on land use change. They were also trained on ethical requirements and the benefits of the 
project to the community. The process of obtaining informed consent was also discussed. 
Sampling procedures were explained in detail. The roles of the clinicians and laboratory technicians were clearly 
stipulated. A work plan was then developed. 
Meetings with the Medical officers of health and medical superintendents were held in Hola and Bura hospitals. 
Medical officers of health for Ijara and Sangailu were contacted on phone. Materials for the survey were 
distributed to all the hospitals and the sampling initialized. 
Training  
Objectives of the human RVF study 
A review of the objectives of the human component of the RVF case study was highlighted as follows: 
1. To determine whether land use changes associated with the development of irrigation schemes 
promote the occurrence and persistence of RVF in people. 
2. To determine relative prevalence of pathogens that should be considered for differential diagnosis of 
febrile diseases in humans. Diseases that present like RVF include yellow fever, Dengue fever, 
Chikungunya, brucellosis, leptospirosis, typhoid, malaria and leishmaniasis. 
3. To assess whether the impacts of RVF in irrigated areas (Tana River District) differ both quantitatively 
and qualitatively from those observed in a pastoral area (in Ijara District) with minimal land use change. 
4. To build capacity among the local public and veterinary health service providers in surveillance and 
diagnosis of RVF and related febrile illnesses. 
3 
 
 
Plate 1. Discussing the objectives of the study and ethics. 
 
Study design of hospital survey 
A systematic sampling technique was explained. The participants were then asked to calculate their sampling 
intervals: 
Hola: Every eighth patient presenting with fever for the last 14 days to be sampled. The facility sees 3600 febrile 
cases on average for three months. 
Bura: Every third patient presenting with fever for the last 14 days to be sampled. The facility sees 1500 febrile 
cases on average for three months 
Ijara and Sangailu: All patients presenting with fever for the last 14 days to be sampled. These facilities have 
fewer cases of fever. 
A total of 474 samples are anticipated from each of the four hospitals after three months. The target population 
is all people above five years of age. 
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Plate 2. Discussions on the hospital study design. 
 
Ethics and consenting 
The general principles that govern ethics in human health research were discussed; those reviewed included: 
 Autonomy: Researchers must allow potential subjects to make choices. The investigator must ensure 
that the participant has received a full disclosure of the nature of the study, the risks, benefits and 
alternatives, with an extended opportunity to ask questions. 
 Beneficence: The investigator must attempt to maximize benefits for the individual participant and/or 
society, while minimizing risk of harm to the individual. 
 Justice: Equitable selection of participants, benefits or burdens among groups likely to participate in 
research. 
Principles of informed consent were also reviewed as listed below: 
Disclosure 
 That the individual is invited to participate in the research, reasons for considering the individual and 
that participation is voluntary. 
 That the individual is free to refuse to participate and will be free to withdraw without penalty or loss 
of benefits to which he or she will be entitled to. 
 The purpose for the research, procedures to be carried out by the investigator and the subject and an 
explanation of how the research differs from routine medical care. 
 Features of the research design. 
 Expected duration of the subject’s participation. 
5 
 
 Whether money or other material good will be provided in return for participation. 
 Subjects will be informed of research findings in general and individual subjects will be informed of any 
finding that relates to their particular health status. 
 Any foreseeable risks associated with participation in the study. 
 Benefits of participation to the society at large. 
 For how long and where the samples will be stored. 
 That treatment will be provided for specific types of injuries or complications associated with the 
study. 
 That an ethical review has cleared the study. 
Understanding 
 The participant must understand what has been explained and must be given an opportunity to ask 
questions. 
Voluntariness 
 Participation should be voluntary, free of coercion or promises of benefits. 
Competence 
 Participants must be competent to give consent. 
 If not, due to mental illness, disease or emergency, a surrogate may provide consent if it is in the best 
interest for the person to participate. 
Consent 
 Potential subject must authorize his or her participation in the research, preferably in writing. 
 
The participants were taken through the consent forms. The process of consenting was discussed. 
 
Blood collection 
Procedures for recruiting subjects and obtaining blood samples were also reviewed in detail. These have been 
described in detail in the proposal. In summary, the points made were: 
 Up to 10 ml (adults) and 5 ml (children) venous blood will be collected from all participants using 
vacutainer butterfly needles. Half of this sample will be collected in heparinised vacutainer tubes for 
pathogen identification using targeted multiplex PCR screening. The other half will be collected in non-
heparinised vacutainer tubes for serological analysis. 
 Samples will be barcoded and linked to the participant and other metadata. 
 The blood and serum samples will be transported in dry shippers to ILRI Nairobi where they will be kept 
at -196°C until analysed at the Kenya Medical Research Institute. 
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Barcoding 
The participants were trained on how to barcode the various blood collection and storage tubes. The barcode 
with prefix BDT was for barcoding heparinized vacutainers while those with prefix BSR were for barcoding non-
heparinised vacutainers. These should be placed vertically for the ease of scanning. Another barcode for cryo 
vials was demonstrated. 
 
Questionnaire survey 
The participants were taken through the process of filling a questionnaire in a computer. 
 
Plate 3. Demonstrating questionnaire administration using computer. 
 
Initiation of hospital survey 
Meeting with medical officers of health and medical superintendent 
Meetings were convened with medical officers of health from Hola and Bura and the Hola District Hospital 
medical superintendent. Those from Ijara and Sangailu were contacted on phone. They were introduced to the 
DDDAC project and the need for their support during the implementation. They promised to support the 
implementation. 
Setting up of sampling materials 
Materials for the sampling were distributed to all the four hospitals (Table 1). 
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Table 1: Sampling materials distributed 
Item Quantity per hospital 
Vacutainer needle Holders 500 
Laptop+scanner+charger One each 
Alcohol swabs 1000 
Butterfly needles 500 
Absolute alcohol 2 
Transfer pipettes 500, Bura 300 
Elastoplast 700 
Cryo vials 1300 
Microscope slides 500 
cotton wool rolls 2 
Vacutainer tubes - heparinised 500 
Vacutainer tubes - non heparinised 500 
Gloves 1000 
Gauze 2 
Racks 20 
Cryo vials 1300 
Small cool box with ice packs 1 
Microscope slides 500 
Cryo boxes 2 
Waste bin and waste papers 1 
Sharp containers 12 
Tourniquet 2 
Dry shipper 1 
BDT barcodes 500 
BSR barcodes 500 
AVAQ barcodes 2000 
File 1 
Paper punch 1 
Fever checklist Hola 160, Bura 100, Ijara 100, Sangailu 100 
Consent forms: 5-12 50 
Consent forms; 13-17 50 
Consent forms: adults 60 
 
Materials to be supplied later include: 700 cryo vials per hospital, 500 pasteur pipettes in Hola, Sangailu and 
Ijara, 700 pasteur pipettes in Bura, fever checklists and consent forms. 
Giemsa stains, slide racks and Brucella reagents should also be supplied. 
The aliquoting process was then demonstrated. This involved data entry using a computer. The procedure is as 
follows: 
1. Arrange the mother samples and their respective daughters in the rack. Precaution: AVOID KNOCKING 
THE ARRANGED ALIQUOTS. 
2. Start the computer 
3. Fix the scanner and mouse to the computer 
4. Click on ‘Google chrome’ icon on the desktop 
5. Click on ‘sort samples’ tab 
6. Click on ‘1.aliquot samples’ 
***start with whole blood/BDT*** 
7. Click on ‘save’ 
8. Click on ‘save’ again 
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**Use the provided cryo boxes/trays - labelled TWAQ and TLST** 
9. Scan the first BDT tube 
10. Scan the first daughter tube 
11. Edit the ‘tray id’ to TWAQ ……………….. 
12. Place the daughter sample in the TWAQ cryo box/tray as indicated in the computer 
13. Place the cursor at ‘FIND’ 
14. Scan the next daughter sample 
15. Edit the ‘tray id’ to TLST ……………….. 
16. Place the cursor at ‘FIND’ 
17. Place the daughter sample in the TLST cryo box/tray as indicated in the computer 
18. Scan the next BDT tube and its respective daughter samples. 
19. Do the same to the remaining samples. 
20. Scan the last daughter sample twice. A red line appears 
21. put the TWAQ samples in canister BW 
22. put the TLST samples in canister BL 
***SERUM/BSR*** 
23. on the computer, click ‘home’ 
24. click on ‘1.aliquot samples’ 
25. edit ‘BDT 6’ to ‘BSR 6’ 
26. click on ‘save’ 
27. click on ‘save’ again 
28. scan the first BSR tube 
29. Scan the first daughter tube 
30. Edit the ‘try id’ to TWAQ ……………….. 
31. Place the daughter sample in the TWAQ cryo box/tray as indicated in the computer 
32. Place the cursor at ‘FIND’ 
33. Scan the next daughter sample 
34. Edit the ‘try id’ to TLST ……………….. 
35. Place the cursor at ‘FIND’ 
36. Place the daughter sample in the TLST cryo box/tray as indicated in the computer 
37. Scan the next BSR tube and its respective daughter samples. 
38. Do the same to the remaining sample. 
39. Scan the last daughter sample twice. A red line appears 
40. put the TWAQ samples in canister SW 
41. put the TLST samples in canister SL 
42. The next day, start the computer and follow the above procedure. Note: after scanning the next day’s 
tube, the computer takes you to the next position of the aliquot in the tray. So, do no editing. Edit only 
when switching from BDT to BSR. 
43. After a tray is full (100 samples), edit to the next tray id. 
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Plate 4. Demonstrating the aliquoting process. 
Work plan 
A work plan was developed to initiate the hospital survey (Table 2).  
Table 2: dates for hospital survey initiation 
Hospital Date 
Hola 12 March 2014 
Bura 13 March 2014 
Ijara and Sangailu 14 March 2014 
 
The roles for the clinicians and the laboratory technicians were stipulated: 
Clinicians 
i. Systematically sample patients 
ii. Obtain informed consent from the participants 
iii. Fill in the fever checklist 
iv. Make a line list of all selected patients 
Laboratory technicians 
i. Confirm the selected patients 
ii. Witness the consenting 
iii. Indicate BSR codes in both the fever checklist and the consent form 
iv. Collect blood 
v. Fill in the questionnaire 
vi. Aliquot the collected samples 
vii. Make a thin/thick smear for malaria microscopy 
viii. Put aliquoted samples into dry shippers. 
ix. Issue the following to ILRI driver: dry shipper with samples, slides, data in flash disk and consent 
forms. 
x. Receive the dry shipper from ILRI driver. 
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List of participants 
Serial 
No.  
Name Designation Sex 
(M/F) 
Country of 
origin 
Country Classification 
(Developing/Developed) 
1 Damaris Mwololo MSc Student, ILRI F Kenya Developing  
2 Jason Rogena Systems Developer, ILRI M Kenya Developing  
3 Joan Karanja Medical Epidemiologist, MPH F Kenya Developing  
4 John Muriuki MSc student, ILRI M Kenya Developing  
5 Saeed Adan Lab Technologist, MPH M Kenya Developing  
6 Peter Lokamar Medical Epidemiologist, MPH M Kenya Developing  
7 Stephen Kitundu Lab Technologist, MPH M Kenya Developing  
8 Godfrey Mutua Lab Technologist, MPH M Kenya Developing  
9 Said Shushe Wario Lab Technician, MPH M Kenya Developing  
10 Patrick Mbandi Lab Technician M Kenya Developing  
11 Bernard Bett Epidemiologist, ILRI M Kenya Developing  
12 Charo Jepha Clinical Officer, Hola M Kenya Developing  
13 Jackson Gitonga Nursing Officer, Ijara M Kenya Developing  
14 Daniel Mabombe Clinical Officer, Bura M Kenya Developing  
15 Dr Mwangi Medical Superintendent, Hola M Kenya Developing  
16 Dr Fred Medical Officer of Health, 
Hola 
M Kenya Developing  
17 Dr Ayako Ag. Medical Officer of Health, 
Bura 
M Kenya Developing  
 
